Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Dec 2023 |
---|---|---|---|---|
Total reported revenue | 0 | 0 | 0 | 0 |
Cost of revenue | — | — | — | — |
Gross profit | — | — | — | — |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 352.6K | 735.1K | 236.2K | 319.7K |
Other operating expenses | 81.8K | 172.4K | 27.3K | 73.2K |
Operating income | -434.4K | -907.5K | -263.5K | -392.9K |
Non operating interest income | ||||
Income | 3.4K | 2.6K | 2.7K | 1.4K |
Expense | — | — | — | — |
Other income expense | 7.9K | -3.0M | 24.3K | 27.6K |
Pretax income | -423.1K | -3.9M | -236.5K | -363.9K |
Tax provision | 0 | 0 | 0 | — |
Net income | -423.1K | -3.9M | -236.5K | -363.9K |
Basic EPS | 0.0 | — | 0.0 | — |
Diluted EPS | 0.0 | — | 0.0 | — |
Basic average shares | 340.6M | — | 245.0M | — |
Diluted average shares | 340.6M | — | 245.0M | — |
EBITDA | -442.2K | 1.9M | -287.8K | -420.5K |
Net income from continuing op. | -423.1K | -3.9M | -236.5K | -363.9K |
Minority interests | — | — | — | — |
Preferred stock dividends | — | — | — | — |